International Urology and Nephrology

, Volume 41, Issue 3, pp 559–565

The use of the Ki-67 marker in the pathological diagnosis of the epithelioid variant of renal angiomyolipoma

  • Sue Min Ooi
  • Justin B. Vivian
  • Ronald J. Cohen
Urology - Original Paper

Abstract

Objective:

Epithelioid angiomyolipoma (EAML) is a rare malignant variant of renal angiomyolipoma (AML). There were 34 cases of EAML reported in 25 studies (including this present study) over the past decade. About 68% were females and 32% males. The mean age was 40.1 years, 53% developed metastatic disease after nephrectomy, and eight patients had TSC. All cases are reported positive when stained with HMB-45 which also labels all classical AML. This study evaluates the use of Ki-67 (proliferation marker) in the pathological diagnosis of EAML and distinction from classical AML.

Method:

Immunohistochemical reactions for Ki-67 were generated on multiple representative blocks of tissue obtained from two cases of HMB-45 positive EAML and four cases of classic AML and the percentage of positively staining cells estimated.

Results:

Both cases of EAML were strongly positive for Ki-67 while all four classic AML were completely negative.

Conclusion:

The Ki67 is a useful marker in which distinguishes the malignant epithelioid variant of AML from classic AML.

Keywords

Epithelioid variant Renal angiomyolipoma Renal Ki-67 Proliferative marker 

References

  1. 1.
    Neumann H, Henske E, Iliopoulos O et al (2005) Renal involvement in tuberous sclerosis and von Hippel-Lindau disease. In: Davison A, Cameron J, Grunfeld J (eds) Oxford Textbook of Clinical Nephrology, 3rd edn. Oxford University Press, New York, pp 2397–2401Google Scholar
  2. 2.
    Nelson CP, Sanda MG (2002) Contemporary diagnosis and management of renal angiomyolipoma. J Urol 168:1315–1325PubMedCrossRefGoogle Scholar
  3. 3.
    Ferry JA, Malt RA, Young RH (1991) Renal angiomyolipoma with sarcomatous transformation and pulmonary metastases. Am J Surg Pathol 15(11):1083–1088PubMedCrossRefGoogle Scholar
  4. 4.
    Stone CH, Lee MW, Amin MB (2001) Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum. Arch Pathol Lab Med 125:751–758PubMedGoogle Scholar
  5. 5.
    Lowe BA, Brewer J, Houghton DC et al (1992) Malignant transformation of angiomyolipoma. J Urol 147:1356–1358PubMedGoogle Scholar
  6. 6.
    Lopez-Beltran A, Scarpelli M, Montironi R et al (2006) 2004 WHO classification of the renal tumours of the adults. Eur Urol 49(5):798–805PubMedCrossRefGoogle Scholar
  7. 7.
    Svec A, Velenska Z (2004) Renal epithelioid angiomyolipoma—a close mimic of renal cell carcinoma. Report of a case and review of the literature. Pathol Res Pract 200:851–856CrossRefGoogle Scholar
  8. 8.
    Bonetti F, Pea M, Martignoni G et al (1994) Clear cell (“sugar”) tumor of the lung is a lesion strictly related to angiomyolipoma: the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology 26:230–236PubMedCrossRefGoogle Scholar
  9. 9.
    Martignoni G, Pea M, Bonetti F et al (1998) Carcinoma-like monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study. Am J Surg Pathol 22:663PubMedCrossRefGoogle Scholar
  10. 10.
    Eble JN, Amin MB, Young RH (1997) Epithelioid angiomyolipoma of the kidney. A report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. Am J Surg Path 21:1123–1130PubMedCrossRefGoogle Scholar
  11. 11.
    Eble JN (1998) Angiomyolipoma of kidney. Semin Diagn Pathol 15:21–40PubMedGoogle Scholar
  12. 12.
    Henske EP, Neumann HPH, Scheitauer BW et al (1995) Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipoma. Genes Chromosomes Cancer 13:295–298PubMedCrossRefGoogle Scholar
  13. 13.
    Chandrasoma S, Moatamed N, Chang A et al (2004) Angiomyolipoma of the kidney: expanding disease spectrum demonstrated by 3 cases. Appl Immunohistochem Mol Morphol 12:277–283PubMedGoogle Scholar
  14. 14.
    Frago PS, Camison CDAA, Sanz MJG et al (2006) Controversies related to epithelioid variant of renal angiomyolipoma: a review of the literature. Urology 67:846.e3–846.e5CrossRefGoogle Scholar
  15. 15.
    Kattar MM, Grignon DJ, Eble HN et al (1999) Chromosomal analysis of renal angiomyolipoma by comparative genomic hybridisation: evidence for clonal origin. Hum Pathol 30(3):295–299PubMedCrossRefGoogle Scholar
  16. 16.
    Oesterling JE, Fishman EK, Goldman SM et al (1996) The management of renal angiomyolipoma. J Urol 131:1121Google Scholar
  17. 17.
    Schluter C, Duchrow M, Wohlenberg C et al (1993) The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining protein. J Cell Biol 123:513–522PubMedCrossRefGoogle Scholar
  18. 18.
    Brown DC, Gatter KC (2002) Ki67 protein: the immaculate deception? Histopathology 40:2–11PubMedCrossRefGoogle Scholar
  19. 19.
    Cho NH, Shim HS, Choi YD et al (2004) Estrogen receptor is significantly associated with the epithelioid variants of renal angiomyolipoma: a clinicopathological and immunohistochemical study of 67 cases. Pathol Int 54(7):510–515PubMedCrossRefGoogle Scholar
  20. 20.
    Jarzabek K, Koda M, Kozlowski L et al (2005) Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors. Eur J Cancer 41:2924–2934PubMedCrossRefGoogle Scholar
  21. 21.
    Choi Y, Pinto M (2005) Estrogen receptor beta in breast cancer: associates between ERbeta, hormonal receptors, and other prognostic biomarkers. Appl Immunohistochem Mol Morphol 13:19–24PubMedCrossRefGoogle Scholar
  22. 22.
    Quek ML, Rashida AS, Hsu J et al (2005) Renal epithelioid angiomyolipoma associated with hyperprolactinemia. Urology 65:797.e1–797.e2Google Scholar
  23. 23.
    Yu W, Fraser RB, Gaskin DA et al (2005) C-Kit-positive metastatic malignant pigmented clear-cell epithelioid tumor arising from the kidney in a child without tuberous sclerosis. Ann Diag Pathol 9(6):300–304CrossRefGoogle Scholar
  24. 24.
    Saito K, Fujii Y, Kasahara I et al (2002) Malignant clear cell “sugar” tumor of the kidney: clear cell variant of epithelioid angiomyolipoma. J Urol 168:2533–2534PubMedCrossRefGoogle Scholar
  25. 25.
    Ribalta T, Lloreta J, Munne A et al (2000) Malignant pigmented clear cell epithelioid tumor of the kidney: clear cell (“sugar”) tumor versus malignant melanoma. Hum Pathol 31(4):516–519PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, B.V. 2008

Authors and Affiliations

  • Sue Min Ooi
    • 1
  • Justin B. Vivian
    • 1
  • Ronald J. Cohen
    • 2
  1. 1.Department of UrologyRoyal Perth HospitalPerthAustralia
  2. 2.Department of PathologyUroPathPerthAustralia

Personalised recommendations